A Preview of SahmAdrangi’s Success

$100 million is the amount that Kerrisdale Capital Management that is headed by SahmAdrangi managed to raise from investors. The amount is to be used on betting against one stock. This value is considered the first of its nature. Hedge fund managers commonly raise money primarily concentrating on particular investment thesis for example residential mortgage securities or even the recovery of energy companies under distress. Since Kirriesdale Capital Management is a small firm based in New York, it intends to use this money to stock a public company that will soon be released.SahmAdrangi informed the investors that the organization had succeeded in raising a significant amount of money within a short duration. They also began managing a company that is worth $10 million, according to the email sent to investors. Today, the organization manages $500 million, including the amount that was raised. For a time over, the company has been known for betting against corporations and making the public know the gamble.

Kerrisdale as taken part in numerous activities which include short positions in companies that make drugs such as Sage Therapeutics, Zagen as well as Globalstar. For the last five years, the hedge fund has had an annual return of 28 percent.SahmAdrangi founded Kerrisdale in the year 2009 with less than a million dollars. As at July 2017, the company managed a total of $150 million. He sits as the chief executive officer of the firm. He is knowledgeable about stocks and readily shares this knowledge in the social media especially on his Facebook account.In the year 2010 and 2011, SahmAdrangi created a name for himself when he exposed several Chinese companies that were fraudulent namely China Marine Food Chain, Lihua International, China-Biotics among others. He shares his research on various companies. Of late, his focus has been on the biotechnology sector as well as the mining industry. Besides publishing his research, SahmAdrangi is an investor. He has invested in Lindsay Corporation management. SahmAdrangi is a holder of a bachelor of arts in economics which he earned from Yale University.

Daniel M. Harrison; Heading Monkey Capital

Daniel M. Harrison is an author and also an entrepreneur. He is considered to be the foremost global authorities on international events, millennial culture and also businesses. This has made him be accredited as one to watch by the bestselling author Jeffrey Robinson. Harrison has also been hailed as a serial entrepreneur and bitcoin enthusiast having been a direct descendant of the Harrison bloodline. He is an Asian based entrepreneur and also a technology enthusiast. Harrison is currently the managing partner of the south-east Asia investor consortium. The firm deals with the high growth deals within the East Asia region.

Recently monkey capital evolved the ICO market that has a big potential for the Bitcoin and ethereal style gains. Monkey capital is a decentralized hedge fund that invests in blockchain systems, hostile public company takeovers and also simultaneously speculating on the large blocks of crypto. With this, it has been able to rise and be the first ICO to sell options successfully. The company blends with its top-flight management and thus compelling big projects with big giants like the Tesla company. This way they have been able to hype the markets.

The company offers the ICO where the buyers can subscribe for Monkey. Here that will be able to buy tokens. Worth noting is that also they offer the COEVAL. This allows the potential buyers to be able to purchase the tokens at a reduced rate. This complementing the companies’ stocks and reasoning the functionality.

Daniel Mark Harrison

Daniel is the chairman and chief executive officer of the global company that is the Daniel Mark Harrison and Co. it is a family office that operates largely in Singapore, Bangkok, and Hong Kong cities. Harrison is also the managing partner at Monkey Capital and fin tech.

Daniel is also an expansive individual. He is the author of The Millennial Reincarnations, which  was published in the year 2015. Also in the same year, Harrison published the book, Butterflies that captured the strange metamorphosis about the fact and fiction of the today world. He has also ventured in journalism where he has written dozens of articles about the global publications including Forbes.

Disrupting Cancer and Ageing with Mikhail Blagosklonny

In the world of Oncology, very few have been able to reach the heights attained by Mikhail Blagosklonny. He is an Oncology professor and scientist at the Rosewell Park Cancer Institute in Buffalo, New York and concentrates his study on ageing and cancer. Mikhail’s contribution towards the field of Oncology is immense and unparalleled.He has worked in different places, conducting a lot of research and studies on cancer and therapies. This has enabled Mikhail Blagosklonny to gain a lot of skills hence making him an exceptional professor.Aside from that, he also doubles as the Editor- in-Chief of the Oncotarget publication. This is a weekly medical journal whose primary focus is on ageing. It was launched in 2010. Additionally, Mikhail is the associate editor of therapy and cancer biology. He is also on the editorial board of Cell Differentiation and Death.

Blagosklonny’s Career and Education Background spans across many years of extensive research and study. He holds an MD in Internal Medicine as well as a PhD in Cardiology and Experimental Medicine from the First Pavlov State Medical University of St. Petersburg.He has previously worked with New York Medical College as an associate professor of Medicine and Ordway Research Institute as a senior scientist. In 2009 however, Mikhail became an Oncology Professor at the Roswell Park Cancer Institute.Most of Mikhail’s research focuses on cancer and most importantly anti-aging drugs and cancer therapies. Mikhail is also well known for Rapamycin, a cancer drug that he greatly advocates for. This is because it is said to increase the lifespan of a human being.His extensive research on the drug Rapamycin has included clinical investigations, molecular biology, and cellular biology. Most of his studies are guided by the theory of ageing hyperfunction.

All through his work, his passion for a disease free community stands out. His drive to achieve this is what made him venture into Oncology and research.Mikhail Blagosklonny does not only work with his patients to help them recover, he also engages with other cancer experts to find solutions to the cancer menace. He believes that by putting their brains together, they are able to devolve complex situations and find solutions.Through this, he hopes he will be able to find the cure to cancer. It is clearly bearing fruits as he has made very many strides.Through his publication Oncotarget, Mikhail Blagosklonny has documented his strides and interactions with his peers. This is captured in the peer review segment of the publication.His collaborations with them on different cancer findings has helped many patients experience better treatment.His target for the Oncotarget is to bring many experts and enabling them to work together in the different research situations and subjects.The publication has now seen more and more peers join his team to study how to beat cancer. Not only Oncologists but also neurologists, endocrinologists and other doctors have joined in thanks to the work of Mikhail Blagosklonny and Oncotarget.Medicine students have also been incorporated to learn these new techniques as taught by Mikhail Blagosklonny and make use of it in their practice. They are also able to consult Mikhail Blagosklonny and his team as often as possible.

Be A Leader, Not A Boss

From the podcast, we gather that for an individual in a top position to be a success, they have to learn how to be a leader and not a boss. Leaders work alongside their subordinates towards achieving the objectives and the goals that they have all set. More importantly, the leader inspires and motivates their subordinates to greatness which makes them admired and a role model to the others.

 

 

This podcast is useful to entrepreneurs and individuals in a top position in their companies. They need to learn how they can use their positions to inspire greatness to their subordinates. Moreover, leaders need to understand that subordinates are not there to be seen and worked. Instead, for a healthy relationship and great result, subordinates need to be listened and encouraged. This is a leaf that most leaders fail to understand when dealing with their subordinates.

 

 

More importantly, passion and ambition go hand in hand. Both leaders and subordinates should be encouraged to know what they are passionate about. Leaders should learn and try to understand their subordinates, their strengths and weaknesses and what they are passionate about. From there, they should be given roles and duties that they have shown great interests in. especially in team work, putting people with different interests together makes it easy for them to succeed in the projects as they are all assigned tasks that they love and enjoy doing.

 

 

Josh Verne is an ambitious and passionate entrepreneur based in the United States. His passions lean towards commerce and internet based businesses that he has developed and established in more than twenty years. He has founded several business with his latest and current establishment being the FlockU, LLC. FlockU provides a platform for college students to share ideas in different subjects that affects students.

 

 

Josh also served as the chief executive officer and president for Workpays.me, a site that enabled their users to buy products and services conveniently. He was also the president of Home Line Furniture for sixteen years, a company that was dedicated to proving home equipment and furniture to their clients. His passion and great leadership qualities have been seen through his twenty years of experience in management.

Find out more about Josh Verne:

http://www.xconomy.com/san-diego/2014/03/25/global-analytics-buys-workpays-me-plans-disruptive-entry-in-u-s/2/